[Follow-up of Reverin-treated patients in manifest, primary, secondary, tertiary and latent seropositive lues. IV].
D004352:Drug Resistance, Microbial; D005500:Follow-Up Studies; D006801:Humans; D012382:Rolitetracycline / Q000627:therapeutic use*; D013587:Syphilis / Q000188:drug therapy*; D013588:Syphilis Serodiagnosis; D013592:Syphilis, Latent / Q000188:drug therapy*; D014209:Treponema Immobilization Test
D012382:Rolitetracycline
Nachkontrolle Reverin-behandelter Patienten bei manifester, primärer, sekundärer, tertiärer und latenter seropositiver Lues. IV.